Cite
Effect of Bevacizumab in Combination with Standard Oxaliplatin-Based Regimens in Patients with Metastatic Colorectal Cancer: A Randomized Clinical Trial
MLA
Paolo Delrio, et al. Effect of Bevacizumab in Combination with Standard Oxaliplatin-Based Regimens in Patients with Metastatic Colorectal Cancer: A Randomized Clinical Trial. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f44f0b9aa49a293b365fd920f4e98cf4&authtype=sso&custid=ns315887.
APA
Paolo Delrio, Domenico Bilancia, G. Rosati, Lucrezia Silvestro, Chiara Carlomagno, F. Perrone, Luigi Aloj, Gerardo Botti, Antonino Cassata, Anna Nappi, Guglielmo Nasti, Secondo Lastoria, Antonella Petrillo, Fabiana Tatangelo, A. Avallone, Alessandra Leone, Carmela Romano, Elena Di Gennaro, Laura Arenare, … Ciro Gallo. (2021). Effect of Bevacizumab in Combination with Standard Oxaliplatin-Based Regimens in Patients with Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Chicago
Paolo Delrio, Domenico Bilancia, G. Rosati, Lucrezia Silvestro, Chiara Carlomagno, F. Perrone, Luigi Aloj, et al. 2021. “Effect of Bevacizumab in Combination with Standard Oxaliplatin-Based Regimens in Patients with Metastatic Colorectal Cancer: A Randomized Clinical Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f44f0b9aa49a293b365fd920f4e98cf4&authtype=sso&custid=ns315887.